A Prospective Multicenter Study of Symptoms and QOL in Patients With Prostate and Rectal Cancers Receiving Palliative Pelvic Radiation
With the aging population, the prevalence of cancer is on the rise, leading to an increased
demand for effective palliative treatment. There is little scientific information describing
the effects of palliative radiotherapy among patients treated for soft-tissue tumors of the
pelvis. This is a treatment that is used relatively frequently, but delivered
heterogeneously since the optimum fractionation schedule has yet to be established. This
study aims to define the effects of one such fractionation schedule (3Gy x 10-13) and thus,
establish a foundation for future fractionation studies.
Observational Model: Case-Only, Time Perspective: Prospective
Effect on patient's target symptom.
at end of treatment and 6 weeks and 12 weeks after treatment completion
Norway:National Committee for Medical and Health Research Ethics